Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

Item
http://www.wikidata.org/entity/Q33433804
Major clinical research advances in gynecologic cancer in 2016: 10-year special edition.Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.UGT1A1 polymorphisms in cancer: impact on irinotecan treatment.Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.Networking for ovarian rare tumors: a significant breakthrough improving disease management.Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.Triple Synchronous Primary Neoplasms of the Cervix, Endometrium, and Ovary: A Rare Case Report and Summary of All the English PubMed-Indexed Literature.Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysisIdentification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer.Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis.Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway.Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer.Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience
P2860

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

Item
http://www.wikidata.org/entity/Q33433804
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Randomized Phase III Trial of ...... arcinoma: JGOG3017/GCIG Trial.
@ast
Randomized Phase III Trial of ...... arcinoma: JGOG3017/GCIG Trial.
@en
type
label
Randomized Phase III Trial of ...... arcinoma: JGOG3017/GCIG Trial.
@ast
Randomized Phase III Trial of ...... arcinoma: JGOG3017/GCIG Trial.
@en
prefLabel
Randomized Phase III Trial of ...... arcinoma: JGOG3017/GCIG Trial.
@ast
Randomized Phase III Trial of ...... arcinoma: JGOG3017/GCIG Trial.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Randomized Phase III Trial of ...... arcinoma: JGOG3017/GCIG Trial.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921